TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/24 18:52 | 11/19/24 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kurtoglu Metin | MD | O | CTO | M.dm | 55 | 1.41 | 0 | 39 | 313 | 51 | D | ||||||||||||||
11/21/24 18:52 | 11/19/24 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kurtoglu Metin | MD | O | CTO | S.dm | -649 | 16.78 | 0 | -39 | -43 | 51 | D | ||||||||||||||
11/18/24 19:32 | 11/14/24 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kurtoglu Metin | MD | O | CTO | M.dm | 116 | 1.41 | 0 | 82 | 51 | D | |||||||||||||||
11/18/24 19:32 | 11/14/24 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kurtoglu Metin | MD | O | CTO | S.dm | -1,438 | 17.46 | 0 | -82 | -62 | 51 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |